Gabriele E. Bugaisky

Array ( [id] => 14596757 [patent_doc_number] => 10351560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Crystalline forms [patent_app_type] => utility [patent_app_number] => 15/759710 [patent_app_country] => US [patent_app_date] => 2016-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9769 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16498812 [patent_doc_number] => 10864179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma [patent_app_type] => utility [patent_app_number] => 15/764781 [patent_app_country] => US [patent_app_date] => 2016-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 22 [patent_no_of_words] => 18436 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13385963 [patent_doc_number] => 20180244523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => PRODUCTION OF HYPERPOLARIZED GAS [patent_app_type] => utility [patent_app_number] => 15/758189 [patent_app_country] => US [patent_app_date] => 2016-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7810 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13389171 [patent_doc_number] => 20180246128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => DIAGNOSTIC METHODS AND KITS [patent_app_type] => utility [patent_app_number] => 15/757267 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12016905 [patent_doc_number] => 09809597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy' [patent_app_type] => utility [patent_app_number] => 15/241821 [patent_app_country] => US [patent_app_date] => 2016-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 14764 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16861670 [patent_doc_number] => 11020392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => Use of trimetazidine as a hepatoprotective medicine in prevention and treatment of liver diseases and conditions [patent_app_type] => utility [patent_app_number] => 15/240677 [patent_app_country] => US [patent_app_date] => 2016-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7524 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13386165 [patent_doc_number] => 20180244624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => NOVEL ISONITRAMINE COMPOUND AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING METABOLIC DISEASES [patent_app_type] => utility [patent_app_number] => 15/752592 [patent_app_country] => US [patent_app_date] => 2016-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13342433 [patent_doc_number] => 20180222756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => Preparation Method For Modified Molecular Sieve And Modified Molecular Sieve-Containing Catalytic Cracking Catalyst [patent_app_type] => utility [patent_app_number] => 15/750403 [patent_app_country] => US [patent_app_date] => 2016-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11290451 [patent_doc_number] => 20160340383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => '(3A,9B,10A,13A,14B,17A,20S,22E)-ERGOSTA-5,7,22-TRIEN-3-OL AND METHODS OF PREPARING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/227936 [patent_app_country] => US [patent_app_date] => 2016-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10678 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15227936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11400330 [patent_doc_number] => 20170020867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'USE OF MASITINIB FOR THE TREATMENT OF CROHN\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 15/215777 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12096 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15215777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13410743 [patent_doc_number] => 20180256914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS ASSOCIATED WITH TREATMENT-INDUCED NEUTROPENIA [patent_app_type] => utility [patent_app_number] => 15/745827 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13926883 [patent_doc_number] => 20190046957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => A Process For Regenerating An Adsorbent For Nitrogen-Containing Compounds Present In A Hydrocarbon Feed [patent_app_type] => utility [patent_app_number] => 15/759743 [patent_app_country] => US [patent_app_date] => 2016-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12387630 [patent_doc_number] => 09963447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-08 [patent_title] => Substituted 4-azaindoles and their use as GluN2B receptor modulators [patent_app_type] => utility [patent_app_number] => 15/205632 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75615 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12086795 [patent_doc_number] => 09840513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'Substituted tricyclics and method of use' [patent_app_type] => utility [patent_app_number] => 15/205512 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 217495 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11662537 [patent_doc_number] => 20170151239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => '2,4-Pyrimidinediamine Compounds and Their Uses' [patent_app_type] => utility [patent_app_number] => 15/205725 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 244624 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11419807 [patent_doc_number] => 20170027951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'METHODS AND COMPOSITIONS TO TREAT CANCERS INVOLVING EGFR' [patent_app_type] => utility [patent_app_number] => 15/205894 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19458 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13220443 [patent_doc_number] => 10123981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-13 [patent_title] => Methods for treatment of pelvic pain and/or comorbid conditions [patent_app_type] => utility [patent_app_number] => 15/205309 [patent_app_country] => US [patent_app_date] => 2016-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 56 [patent_no_of_words] => 18981 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16955198 [patent_doc_number] => 11059029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Method for producing an adsorption agent for treating compressed gas and an adsorption device provided with such an adsorption agent [patent_app_type] => utility [patent_app_number] => 15/746295 [patent_app_country] => US [patent_app_date] => 2016-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3517 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364041 [patent_doc_number] => 20170002022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/200307 [patent_app_country] => US [patent_app_date] => 2016-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31775 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200307 [rel_patent_id] =>[rel_patent_doc_number] =>)